Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-a gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity
暂无分享,去创建一个
R. Vigneri | J. Youngren | I. Goldfine | V. Trischitta | P. Sbraccia | M. D’Adamo | L. Frittitta | A. Buongiorno
[1] R. Henry,et al. The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.
[2] L. Groop,et al. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.
[3] J. Olefsky,et al. Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. , 1995, The American journal of clinical nutrition.
[4] D. Goeddel,et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.
[5] C. Bogardus,et al. Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. , 1990, The American journal of physiology.
[6] D. Accili,et al. Mutations in the insulin receptor gene. , 1992, Endocrine reviews.
[7] B. Spiegelman,et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.
[8] Bharat B. Aggarwal,et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.
[9] B. Goldstein,et al. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. , 1995, The Journal of clinical investigation.
[10] R. Considine,et al. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. , 1995, The Journal of clinical investigation.
[11] J. Olefsky,et al. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. , 1994, The Journal of clinical endocrinology and metabolism.
[12] R. Roth,et al. A nonradioactive assay for the insulin receptor tyrosine kinase: use in monitoring receptor kinase activity after activation of overexpressed protein kinase C alpha and high glucose treatment. , 1995, Analytical biochemistry.
[13] P. Casellas,et al. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. , 1992, The Journal of biological chemistry.
[14] G. Dohm,et al. Skeletal Muscle Content of Membrane Glycoprotein PC-1 in Obesity: Relationship to Muscle Glucose Transport , 1996, Diabetes.
[15] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[16] R. Roth,et al. Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells. , 1990, The Journal of biological chemistry.
[17] J. Larrick,et al. Competitive PCR , 1992, Nature.
[18] T. Yano,et al. Elevated nucleotide pyrophosphatase activity in cultured skin fibroblasts from patients with Lowe's syndrome. , 1988, Clinica chimica acta; international journal of clinical chemistry.
[19] A. Grupe,et al. Inhibition of Insulin Receptor Phosphorylation by PC-1 Is Not Mediated by the Hydrolysis of Adenosine Triphosphate or the Generation of Adenosine (*) , 1995, The Journal of Biological Chemistry.
[20] J. Goding,et al. Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissues. , 1988, Journal of immunology.
[21] L. Liotta,et al. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. , 1994, The Journal of biological chemistry.
[22] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[23] R. Bergman,et al. Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin , 1995, Diabetes.
[24] B. Spiegelman,et al. Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.
[25] G. Reaven,et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus , 1995, Nature.
[26] R. DeFronzo,et al. Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.
[27] M. White,et al. A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. , 1989, The Journal of biological chemistry.
[28] D. Accili,et al. Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM? , 1994, Diabetes.
[29] H. Klein,et al. Elevation of Serum Insulin Concentration During Euglycemic Hyperinsulinemic Clamp Studies Leads to Similar Activation of Insulin Receptor Kinase in Skeletal Muscle of Subjects With and Without NIDDM , 1995, Diabetes.
[30] W. Pories,et al. Insulin-Receptor Kinase Activity of Adipose Tissue From Morbidly Obese Humans With and Without NIDDM , 1987, Diabetes.
[31] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[32] N. Rebbe,et al. Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. , 1993, Molecular immunology.
[33] C. R. Kahn,et al. Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.
[34] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[35] M. V. Doyle,et al. Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Zancanaro,et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. , 1989, The Journal of clinical endocrinology and metabolism.
[37] G. Dohm,et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.
[38] H. Maegawa,et al. Impaired Autophosphorylation of Insulin Receptors From Abdominal Skeletal Muscles in Nonobese Subjects With NIDDM , 1991, Diabetes.
[39] C. Bogardus. Insulin Resistance in the Pathogenesis of NIDDM in Pima Indians , 1993, Diabetes Care.
[40] R. Vigneri,et al. A reduced glut 4 content in adipose tissue is not an early defect in the development of human insulin resistance , 1995 .
[41] J. Flier,et al. Normal Insulin-Receptor cDNA Sequence in Pima Indians With NIDDM , 1989, Diabetes.
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] H. Klein,et al. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. , 1987, The Journal of clinical investigation.
[44] P. Björntorp,et al. Glucose uptake in human adipose tissue. , 1987, Metabolism: clinical and experimental.
[45] C. Kahn,et al. Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. , 1988, The Journal of clinical endocrinology and metabolism.
[46] J. Goding,et al. Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. , 1994, European journal of biochemistry.